The Sinus microbiome: a comparison between the healthy sinus and Chronic Rhinosinusitis
Recruiting
- Conditions
- Chronic Rhinosinusitis
- Registration Number
- ACTRN12617000028303
- Lead Sponsor
- niversity of Queensland
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 200
Inclusion Criteria
Not provided
Exclusion Criteria
Not provided
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie the microbial imbalance in chronic rhinosinusitis compared to healthy sinuses as studied in ACTRN12617000028303?
What are the key biomarkers identified in ACTRN12617000028303 for differentiating chronic rhinosinusitis subtypes and predicting treatment response?
How does the sinus microbiome profile in ACTRN12617000028303 inform potential probiotic or microbiome-targeted therapies for chronic rhinosinusitis?
What comparative insights does ACTRN12617000028303 provide on the efficacy of microbiome modulation versus standard-of-care treatments for chronic rhinosinusitis?
What are the potential adverse events associated with microbiome-based interventions for chronic rhinosinusitis as suggested by ACTRN12617000028303 findings?